Skip to main content
. Author manuscript; available in PMC: 2013 Jul 9.
Published in final edited form as: Arthritis Care Res (Hoboken). 2012 Mar;64(3):448–454. doi: 10.1002/acr.21566

Table 1.

Patient and neuropsychological performance characteristics of SLE and RA patients*

Total (n = 221) SLE (n = 139) RA (n = 82)
Age, mean ± SD years 51.8 ± 12.2 47.7 ± 12.4 57.8 ± 11.2
High school education or greater 86 (190) 87 (121) 83 (68)
Women 91 (202) 95 (132) 85 (70)
Income
    <$20,000 16 (35) 22 (30) 6 (5)
    $20,000–39,999 12 (27) 12 (16) 13 (11)
    $40,000–59,999 17 (38) 19 (26) 15 (12)
    $60,000–79,999 13 (29) 14 (20) 11 (9)
    $80,000–99,999 13 (29) 9 (13) 18 (15)
    ≥$100,000 29 (63) 25 (34) 37 (30)
Race/ethnicity
    Hispanic/Latino 10 (21) 11 (15) 7 (6)
    White 66 (146) 56 (78) 83 (68)
    African American 8 (17) 11 (15) 2 (2)
    Asian 12 (27) 15 (21) 7 (6)
    Other 5 (11) 7 (10) 9 (7)
Disease duration, mean ± SD years 18.6 ± 10.9 15.6 ± 9.4 21.1 ± 11.6
Major depressive disorder 15 (32) 18 (25) 9 (7)
Neuropsychological functioning (CRC visit)
    Verbal learning and memory impairment
        CVLT-II learning 12 (27) 15 (21) 9 (7)
        CVLT-II short delay free recall 19 (42) 20 (28) 18 (15)
        CVLT-II long delay free recall 24 (53) 28 (39) 17 (14)
        CVLT-II recognition task 23 (51) 25 (35) 19 (16)
    Visuospatial learning and memory impairment
        Rey Complex Figure Test copy 32 (71) 33 (46) 31 (25)
        Rey immediate delay 24 (53) 30 (42) 14 (12)
        Rey long delay 24 (53) 31 (43) 14 (11)
    Executive functioning impairment
        Color–Word Inhibition 20 (44) 23 (32) 14 (12)
        Card Sorting 17 (38) 19 (26) 14 (12)
        Trail Making (shifting) 18 (40) 19 (26) 17 (14)
    Fluency impairment
        Phonemic fluency 28 (62) 31 (43) 24 (20)
        Semantic fluency 9 (20) 8 (11) 10 (8)
        Design fluency 25 (55) 22 (31) 30 (25)
    Working memory/speeded processing impairment
        Symbol Digit Modalities Test 23 (51) 29 (40) 13 (11)
        Digit span (backward) 8 (18) 7 (10) 9 (7)
    Visuospatial impairment
        Judgment of Line Orientation 15 (33) 18 (25) 8 (7)
    Total number of cognitive tasks impaired, mean ± SD 3.0 ± 2.7 3.45 ± 3.10 2.4 ± 2.2
    At least one-third of cognitive tasks impaired 19 (42) 25 (34) 10 (8)
Neuropsychological function (screening)
    HVLT-R learning 18 (40) 20 (28) 14 (12)
    HVLT-R delayed recall 20 (44) 21 (29) 20 (16)
    Phonemic fluency 28 (62) 31 (43) 25 (21)
    At least one-third of screening tasks impaired 43 (95) 46 (64) 38 (31)
    Self-reported cognitive functioning
        Perceived Deficits Questionnaire-Short Form 7.5 ± 4.3 8.6 ± 4.3 5.6 ± 3.7
*

Values are the percentage (number) unless otherwise indicated. SLE = systemic lupus erythematosus; RA = rheumatoid arthritis; CRC = Clinical Research Center; CVLT-II = California Verbal Learning Test-II; HVLT-R = Hopkins Verbal Learning Test-Revised.